These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23053628)

  • 21. Association of p53 codon Arg72Pro and p73 G4C14-to-A4T14 at exon 2 genetic polymorphisms with the risk of Japanese breast cancer.
    Huang XE; Hamajima N; Katsuda N; Matsuo K; Hirose K; Mizutani M; Iwata H; Miura S; Xiang J; Tokudome S; Tajima K
    Breast Cancer; 2003; 10(4):307-11. PubMed ID: 14634508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between N-acetyltransferase 2 (NAT2) genetic polymorphism and development of breast cancer in post-menopausal Chinese women in Taiwan, an area of great increase in breast cancer incidence.
    Huang CS; Chern HD; Shen CY; Hsu SM; Chang KJ
    Int J Cancer; 1999 Jul; 82(2):175-9. PubMed ID: 10389748
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine double minute clone 2,309T/G and 285G/C promoter single nucleotide polymorphism as a risk factor for breast cancer: a Polish experience.
    Piotrowski P; Lianeri M; Rubis B; Knuła H; Rybczyńska M; Grodecka-Gazdecka S; Jagodziński PP
    Int J Biol Markers; 2012 Jul; 27(2):e105-10. PubMed ID: 22467100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CYP17 gene polymorphism and its association with high-risk north Indian breast cancer patients.
    Chakraborty A; Murthy NS; Chintamani C; Bhatnagar D; Mohil RS; Sharma PC; Saxena S
    J Hum Genet; 2007; 52(2):159-165. PubMed ID: 17235448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of metallothionein 2A polymorphism on lead metabolism: are pregnant women with a heterozygote genotype for metallothionein 2A polymorphism and their newborns at risk of having higher blood lead levels?
    Tekin D; Kayaaltı Z; Söylemezoğlu T
    Int Arch Occup Environ Health; 2012 Aug; 85(6):631-7. PubMed ID: 22005883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for an association of TP53 codon 72 polymorphism with breast cancer risk.
    Damin AP; Frazzon AP; Damin DC; Roehe A; Hermes V; Zettler C; Alexandre CO
    Cancer Detect Prev; 2006; 30(6):523-9. PubMed ID: 17113725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphism in metallothionein 1A (MT1A) is associated with cadmium-related excretion of urinary beta 2-microglobulin.
    Lei L; Chang X; Rentschler G; Tian L; Zhu G; Chen X; Jin T; Broberg K
    Toxicol Appl Pharmacol; 2012 Dec; 265(3):373-9. PubMed ID: 22995156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ile to Val polymorphism at codon 655 of HER-2 gene and breast cancer risk in Iranian women.
    Kamali-Sarvestani E; Talei AR; Merat A
    Cancer Lett; 2004 Nov; 215(1):83-7. PubMed ID: 15374636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
    Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11/Rad50/Nbs1 complex.
    Hsu HM; Wang HC; Chen ST; Hsu GC; Shen CY; Yu JC
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2024-32. PubMed ID: 17932350
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk.
    Xie D; Shu XO; Deng Z; Wen WQ; Creek KE; Dai Q; Gao YT; Jin F; Zheng W
    J Natl Cancer Inst; 2000 Mar; 92(5):412-7. PubMed ID: 10699071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RAD51 genotype and triple-negative breast cancer (TNBC) risk in Polish women.
    Smolarz B; Zadrożny M; Duda-Szymańska J; Makowska M; Samulak D; Michalska MM; Mojs E; Bryś M; Forma E; Romanowicz-Makowska H
    Pol J Pathol; 2013 Apr; 64(1):39-43. PubMed ID: 23625599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Association of
    Hsiao CL; Liu LC; Shih TC; Lai YL; Hsu SW; Wang HC; Pan SY; Shen TC; Tsai CW; Chang WS; Su CH; Way TD; Chung JG; Bau DT
    In Vivo; 2018; 32(3):487-491. PubMed ID: 29695550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metallothionein 2A expression is associated with cell proliferation in breast cancer.
    Jin R; Chow VT; Tan PH; Dheen ST; Duan W; Bay BH
    Carcinogenesis; 2002 Jan; 23(1):81-6. PubMed ID: 11756227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathway-Affecting Single Nucleotide Polymorphisms (SNPs) in RPS6KA1 and MBIP Genes are Associated with Breast Cancer Risk.
    Shareefi G; Turkistani AN; Alsayyah A; Kussaibi H; Abdel Hadi M; Alkharsah KR
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2163-2168. PubMed ID: 32711446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.